4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000130
Chief Medical Officer sold 55,000 shares at an average $16.50 ($907,533)
- Chief Medical Officer acquired 55,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miljkovic Milos Chief Medical Officer | 2024-11-14 | Option exercise | +35,000 | $3.23 | $113,050 | 53,273 | D |
| Miljkovic Milos Chief Medical Officer | 2024-11-14 | Sale | −35,000 | $16.13 | $564,645 | 18,273 | D |
| Miljkovic Milos Chief Medical Officer | 2024-11-15 | Option exercise | +20,000 | $3.23 | $64,600 | 38,273 | D |
| Miljkovic Milos Chief Medical Officer | 2024-11-15 | Sale | −20,000 | $17.14 | $342,888 | 18,273 | D |
| Derivatives | |||||||
| Miljkovic Milos Chief Medical Officer | 2024-11-14 | Option exercise · Stock Option (Right to Buy) | −35,000 | 50,528 | D | ||
| Miljkovic Milos Chief Medical Officer | 2024-11-15 | Option exercise · Stock Option (Right to Buy) | −20,000 | 30,528 | D | ||
| Open-market sales · 55,000 sh · avg $16.50 · $907,533 | |||||||
Loading xslF345X05/wk-form4_1731976078.xml…